Agilent seals deal to buy Lab901

SCOTTISH biotech outfit Lab901 has been snapped up by New York-listed Agilent.

By The Newsroom

Published 2nd Mar 2011, 14:35 BST

Updated 2nd Mar 2011, 20:45 BST

The Loanhead-based firm was founded in 2001 and produces machines that are used to analyse DNA and proteins.

Lab901 chief executive Joel Fearnley said: "We have always recognised the strong synergy between our two companies. Lab901's technology, products and experienced team are a perfect fit with Agilent."

New York